Company profile
Healthleap Inc.
HealthLeap, Inc. is a San Francisco-based clinical decision support company providing daily AI risk screening for adult hospital inpatients. Healthleap's malnutrition module reads each patient's electronic health record every morning and writes a nutrition-risk score into the EHR flowsheet, so registered dietitians can prioritise the highest-risk patients. The validated model combines gradient-boosted decision trees with a large language model that extracts features from clinician notes, and the validation study appeared in Applied Clinical Informatics in November 2025. Healthleap states that the platform is being extended to delirium, aspiration pneumonia, congestive heart failure readmissions and pressure injuries. Hospital partners listed on the company website include Penn Medicine, Cedars-Sinai and UMass Memorial. The product grew out of NutriLeap, a tool built by a clinical dietitian for her colleagues.
- Sector
- Healthcare / Digital Health Platforms, Health Care Administration
- Founded
- 2021
- Ownership
- Private
- Stage
- Startup
- Capital raised
- $39.1m
- Employees
- 11-50
- Business model
- B2B Subscription
Products and services
Healthleap Malnutrition Screening, NutriLeap, EHR-Integrated Daily Risk Scoring, Delirium Screening, Aspiration Pneumonia Screening, Heart Failure Readmission Screening & Pressure Injury Screening
Transactions
| Date | Transaction | Type | Value | Market |
|---|---|---|---|---|
| 14 Oct 2026 | Sequoia Capital, First Round Capital and Hummingbird Ventures invest USD 38 million in Healthleap | Venture Capital | $38m |
Source: Partner Researchers.